Latest News
GC Biopharma secures first Latin American approval for BARYCELA Inj.
...
Iterion Therapeutics reports first patient dosed in phase 1/2 trial of tegavivint in colorectal cancer
26 March 2026 - Clinical-stage biopharmaceutical company Iterion Therapeutics reported on Wednesday that the first patient has been dosed at HonorHealth Research Institute in a phase 1/2 clinical trial evaluating tegavivint, a first-in-class, small m...
Lupin reports tentative FDA approval for Pitolisant Tablets
26 March 2026 - India-based global pharma company Lupin Limited (BSE:500257) (NSE:LUPIN) announced on Wednesday that it has received tentative approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application for Pitoli...
SciTech Development reports early-stage clinical data from Phase 1a trial of ST-001 nanoFenretinide at USCLC Annual Workshop 2026
26 March 2026 - SciTech Development Inc, a clinical-stage oncology company advancing ST-001 nanoFenretinide, said on Wednesday that early-stage clinical data from its ongoing Phase 1a trial will be presented at the USCLC Annual Workshop 2026 in Denve...
Clarity Pharmaceuticals signs copper-64 manufacturing agreement with Theragenics
26 March 2026 - Australia-based clinical-stage radiopharmaceutical company Clarity Pharmaceuticals (ASX:CU6) announced on Wednesday that it has signed a large-scale Manufacturing Supply Agreement for copper-64 with Theragenics, a US manufacturer of m...